Search Within

Inna Khodos

Formats
  1. Journal Article (21)
  2. Meeting Abstract (14)
  3. Book Section (1)
Groups
  1. GSK Faculty (34)
  2. Sloan Kettering Institute Postdocs (34)
  3. Human Oncology and Pathogenesis Program (33)
  4. Department of Pathology and Laboratory Medicine (31)
  5. Tow Center for Developmental Oncology (TCDO) (28)
  6. Department of Medicine (23)

More Groups

People
  1. Elisa De Stanchina (35)
  2. Marissa Mattar (27)
  3. Marc Ladanyi (26)
  4. Romel Somwar (25)
  5. Igor Odintsov (13)
  6. Jo Weng Allan Lui (12)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (1)
  4. 2022 (10)
  5. 2021 (5)
  6. 2020 (5)

More Years

Publications
  1. Cancer Research (4)
  2. Clinical Cancer Research (4)
  3. Journal of Clinical Oncology (3)
  4. Journal of Thoracic Oncology (3)
  5. Cancer Cell (2)
  6. Cancer Discovery (2)

More Publications

Publishers
  1. American Association for Cancer Research (11)
  2. Elsevier Inc. (6)
  3. American Society of Clinical Oncology (5)
  4. Cell Press (3)
  5. Nature Publishing Group (2)
  6. Oxford University Press (2)

More Publishers

Results (36)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities
    Journal Article

    Fiore, D.; Cappelli, L. V.; Zhaoqi, L.; Kotlov, N.; Sorokina, M.; Phillip, J.; Zumbo, P.; Yoffe, L.; Ghione, P.; Wang, A.; more...
    Cell Reports Medicine (2025)

    Fulltext@MSK | Save
  • HER2 antibody-drug conjugates are active against desmoplastic small round cell tumor
    Journal Article

    Zhang, T.; Febres-Aldana, C. A.; Liu, Z.; Dix, J. M.; Cheng, R.; Dematteo, R. G.; Lui, A. J. W.; Khodos, I.; Gili, L.; Mattar, M. S.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Combination of MDM2 and targeted kinase inhibitors results in prolonged tumor control in lung adenocarcinomas with oncogenic tyrosine kinase drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Smith, R. S.; Vojnic, M.; Hayashi, T.; Khodos, I.; Markov, V.; Liu, Z.; Lui, A. J. W.; Bloom, J. L.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Anticancer therapeutic agents
    Book Section

    Khodos, I.; Ray, S. D.
    In Wexler, P. (Eds.) Encyclopedia of Toxicology. 4th ed (2024)

    Fulltext@MSK | Save
  • Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations
    Journal Article

    Miyazaki, I.; Odintsov, I.; Ishida, K.; Lui, A. J. W.; Kato, M.; Suzuki, T.; Zhang, T.; Wakayama, K.; Kurth, R. I.; Cheng, R.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • Prospective clinical genomic profiling of Ewing sarcoma: ERF and FGFR1 mutations as recurrent secondary alterations of potential biologic and therapeutic relevance
    Journal Article

    Ogura, K.; Elkrief, A.; Bowman, A. S.; Koche, R. P.; de Stanchina, E.; Benayed, R.; Mauguen, A.; Mattar, M. S.; Khodos, I.; Meyers, P. A.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Tractable patient-derived models for preclinical therapeutic studies of CNS metastases
    Meeting Abstract

    Vojnic, M.; Odintsov, I.; Offin, M. D.; Lui, A. J. W.; Khodos, I.; Chang, Q.; Mattar, M. S.; De Stanchina, E.; Ladanyi, M.; Somwar, R.
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Comparison of TAS0953/HM06 and selpercatinib in RET fusion-driven preclinical disease models of intracranial metastases
    Meeting Abstract

    Odintsov, I.; Lui, A. J. W.; Ishizawa, K.; Miyazaki, I.; Khodos, I.; Wakayama, K.; Vojnic, M.; Hagen, C. J.; Chang, Q.; Bonifacio, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Vepafestinib is effective in preclinical models of sarcomas with RET fusion including a brain metastasis model
    Meeting Abstract

    Odintsov, I.; Liu, A.; Khodos, I.; Chang, Q.; Giuliano, C.; Mattar, M.; Vojnic, M.; Bonifacio, A.; De Stanchina, E.; Lovati, E.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • TA0953/HM06, a novel RET-specific inhibitor effective in extracranial and CNS disease models of NSCLC with RETfusions
    Meeting Abstract

    Odintsov, I.; Lui, A. J. W.; Delasos, L.; Khodos, I.; Chang, Q.; Mattar, M. S.; Vojnic, M.; Lu, Y. C.; Kunte, S.; Bonifacio, A.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save